Alector (ALEC) FCF Margin Growth (3y) (2021 - 2026)
Alector (ALEC) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 15,064.00 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 6,066.00 |
| 10 | Alector | 168.65 Mn | -37.87 Mn | - | -446,990.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -446,990.00 |
| Dec 31, 2025 | -35,008.00 |
| Sep 30, 2025 | -65,410.00 |
| Jun 30, 2025 | -54,976.00 |
| Mar 31, 2025 | -220,410.00 |
| Dec 31, 2024 | 25,168.00 |
| Sep 30, 2024 | -56,923.00 |
| Jun 30, 2024 | 25,534.00 |
| Mar 31, 2024 | 90,800.00 |
| Dec 31, 2023 | 59,857.00 |
| Sep 30, 2023 | 17,163.00 |
| Jun 30, 2023 | 138,135.00 |
| Mar 31, 2023 | 20,513.00 |
| Dec 31, 2022 | 16,135.00 |
| Sep 30, 2022 | 92,908.00 |
| Jun 30, 2022 | 10,951.00 |
| Mar 31, 2022 | 111,743.00 |
| Dec 31, 2021 | -8,528.00 |
| Sep 30, 2021 | 59,391.00 |
| Jun 30, 2021 | -44,262.00 |